SCHEMBL18952971

SCHEMBL18952971

COC(=O)c1cc2cc(OS(=O)(=O)C(F)(F)F)c(C(=O)OC)cc2cc1OS(=O)(=O)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.41
EPAS1 Q99814 1/20 0.39
CFTR P13569 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
SDHB P21912 1/20 0.36
CXCR2 P25025 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
SOS1 Q07889 1/20 0.35
NOTUM Q6P988 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18952972 0.96 KDM4E (0.42) HSD11B1EPAS1CFTRL3MBTL1SDHB
SCHEMBL16513114 0.92 HSD11B1 (0.50) HSD11B1EPAS1CFTRL3MBTL1SDHB
SCHEMBL852699 0.91 KDM4E (0.48) HSD11B1EPAS1L3MBTL1SDHBKDM4E
SCHEMBL31150577 0.91 KDM4E (0.48) HSD11B1EPAS1L3MBTL1SDHBKDM4E
SCHEMBL14063330 0.89 HSD11B1 (0.46) HSD11B1EPAS1L3MBTL1CXCR2KDM4E
SCHEMBL17877014 0.89 HSD11B1 (0.43) HSD11B1EPAS1CFTRL3MBTL1CXCR2
SCHEMBL17913590 0.88 EPAS1 (0.45) HSD11B1EPAS1KDM4EMEN1KMT2A
SCHEMBL27229877 0.85 KDM4E (0.41) HSD11B1EPAS1CFTRL3MBTL1SDHB
SCHEMBL7214605 0.84 KDM4E (0.49) HSD11B1EPAS1L3MBTL1SDHBKDM4E
SCHEMBL974920 0.82 HSD11B1 (0.45) HSD11B1EPAS1CFTRL3MBTL1SDHB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10793668-B2 Naphthoindacenodithiophenes and polymers CLAP CO., LTD. (KR) 2020-10-06 US disclosed
EP-3386989-B1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2019-10-23 EP disclosed
US-20180362704-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2018-12-20 US disclosed
EP-3386989-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2018-10-17 EP disclosed
WO-2017097924-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2017-06-15 WO disclosed
WO-2017097924-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2017-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10793668-B2 Naphthoindacenodithiophenes and polymers RPS21, NR2C2, NR0B2 HSD11B1 113/4885EPAS1 2166/4885CFTR 4301/4885
US-20180362704-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS RPS21, NR2C2, NR0B2 HSD11B1 113/4885EPAS1 2166/4885CFTR 4301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.